Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.
de Brouwer R, Te Rijdt WP, Hoorntje ET, Amin A, Asselbergs FW, Cox MGPJ, van der Heijden JF, Hillege H, Karper JC, Mahmoud B, van der Meer P, Oomen A, Te Riele ASJM, Silljé HHW, Tan HL, van Tintelen JP, van Veldhuisen DJ, Westenbrink BD, Wiesfeld ACP, Willems TP, van der Zwaag PA, Wilde AAM, de Boer RA, van den Berg MP. de Brouwer R, et al. Among authors: van der heijden jf, van den berg mp, van der meer p, van der zwaag pa, van tintelen jp, van veldhuisen dj. Eur Heart J. 2023 Oct 21;44(40):4284-4287. doi: 10.1093/eurheartj/ehad292. Eur Heart J. 2023. PMID: 37210081 Free PMC article. No abstract available.
Trace element equilibrium in acute heart failure and the effect of empagliflozin.
Weening EH, Al-Mubarak AA, Damman K, Voors AA, van Veldhuisen DJ, Heerspink HJL, Schomburg L, van der Meer P, Bomer N. Weening EH, et al. Among authors: van der meer p, van veldhuisen dj. Eur J Heart Fail. 2023 Mar;25(3):438-440. doi: 10.1002/ejhf.2779. Epub 2023 Feb 6. Eur J Heart Fail. 2023. PMID: 36691898 Free article. No abstract available.
Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study.
Tubben A, Tingen HSA, Prakken NHJ, van Empel VPM, Gorter TM, Meems LMG, Manintveld OC, Rienstra M, Tieleman RG, Glaudemans AWJM, van Veldhuisen DJ, Slart RHJA, Nienhuis HLA, van der Meer P. Tubben A, et al. Among authors: van veldhuisen dj. Eur J Heart Fail. 2024 Mar;26(3):695-698. doi: 10.1002/ejhf.3186. Epub 2024 Mar 4. Eur J Heart Fail. 2024. PMID: 38439596 No abstract available.
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome.
van der Hoef CCS, Boorsma EM, Emmens JE, van Essen BJ, Metra M, Ng LL, Anker SD, Dickstein K, Mordi IR, Dihoum A, Lang CC, van Veldhuisen DJ, Lam CSP, Voors AA. van der Hoef CCS, et al. Among authors: van essen bj, van veldhuisen dj. Eur J Heart Fail. 2023 Feb;25(2):163-173. doi: 10.1002/ejhf.2760. Epub 2023 Jan 16. Eur J Heart Fail. 2023. PMID: 36597718 Free article.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Curtain JP, Adamson C, Kondo T, Butt JH, Desai AS, Zannad F, Rouleau JL, Rohde LE, Kober L, Anand IS, van Veldhuisen DJ, Zile MR, Lefkowitz MP, Solomon SD, Packer M, Petrie MC, Jhund PS, McMurray JJV. Curtain JP, et al. Among authors: van veldhuisen dj. Eur Heart J. 2023 Feb 21;44(8):668-677. doi: 10.1093/eurheartj/ehac801. Eur Heart J. 2023. PMID: 36632831 Free article. Clinical Trial.
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trial.
Monzo L, Girerd N, Duarte K, Ferreira JP, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Pitt B, Zannad F. Monzo L, et al. Among authors: van veldhuisen dj. Eur J Heart Fail. 2023 Aug;25(8):1444-1449. doi: 10.1002/ejhf.2952. Epub 2023 Jul 7. Eur J Heart Fail. 2023. PMID: 37370197 Free article. Clinical Trial.
1,154 results